News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dompe Announces Innovative Treatment in the Fight Against Type 1 Diabetes: Pancreatic Islet Cell Transplantation, a Hope That Has Already Come True


7/11/2013 10:14:13 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MILAN--(BUSINESS WIRE)--Pancreatic islets, containing insulin-producing cells, are isolated from a donor's pancreas and implanted in the liver of the recipient through a simple infusion procedure. Once in place, the transplanted islets begin to produce insulin. This is the mechanism of action of pancreatic islet transplantation, now a reality for those suffering from type 1 diabetes and in particular from the so-called "brittle diabetes", or unstable diabetes, an uncontrolled disease despite medications. To ensure the results of this innovative approach, however, it is necessary to protect the pancreatic islets that are attacked by the immune system of the recipient.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Dompe
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES